In a small non-randomized study, 89 patients with T2DM and CKD (mean eGFR 34.1 ± 11.5 mL/min/1.73 m2), who were poorly controlled or experienced frequent hypoglycemia on oral ADs or NPH insulin, were prescribed insulin glargine at bedtime. This evidence concerns the gene INS and type 2 diabetes mellitus.